Zions Bancorporation, National Association’s LeMaitre Vascular LMAT Stock Holding History

Zions Bancorporation, National Association’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.44K	Buy	+15	New	+$1.54K	﹤0.01%	1355

Other funds holding LMAT

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return

Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

Chatham Capital Group Savannah, Georgia $783M AUM 31.99% 1-Year Est. Return

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

Nations Financial Group Cedar Rapids, Iowa $2.09B AUM 34.27% 1-Year Est. Return

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Zions Bancorporation, National Association's LMAT Position: Q2 2026 in Review

Zions Bancorporation, National Association opened a new position in LeMaitre Vascular (LMAT) in Q2 2026: 15 shares worth $1.44K. The stake represents ﹤0.01% of the portfolio and ranks #1355 among its holdings.

92 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Zions Bancorporation, National Association held 15 shares of LeMaitre Vascular worth $1.44K as of Q2 2026.
LeMaitre Vascular was a new Zions Bancorporation, National Association position in Q2 2026.
LeMaitre Vascular made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #1355 holding.
92 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.